New Guideline Gives Active Surveillance a Boost ...Middle East

Medscape - News
The 2022 guidance for the first time makes active surveillance the recommended treatment for select patients with favorable intermediate-risk Gleason 3+4 prostate cancer. Medscape Medical News

Hence then, the article about new guideline gives active surveillance a boost was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Guideline Gives Active Surveillance a Boost )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Parade - before 2 hours & 28 minute